Exposing Big Pharma’s Greed
Big Pharma has been playing a costly game, manipulating the patent system to keep drug prices sky-high—even on medications developed with taxpayer funding.
At Accountable.US, we’ve uncovered how drug manufacturers use tactics like pay-to-delay, evergreening, patent thickets, and product hopping to block generic competition and maintain their grip on the market. These strategies have allowed companies to rake in billions while Medicare and U.S. taxpayers foot the bill—leaving many patients, especially in lower-income and marginalized communities, struggling to afford the medications they need.
Explore our in-depth research, press releases, and latest news as we expose Big Pharma’s abuses and advocate for accountability in drug pricing. Learn how we’re fighting back against these unfair practices to ensure affordable access to life-saving medications for all Americans.
Press Releases
Press Releases
Medicare Unveils Negotiated Drug Prices Sparked by Biden-Harris Initiative
Today, the Biden-Harris administration unveiled the final negotiated prices for the Inflation Reduction Act’s historic Medicare negotiation program. In 2026, seniors and other Medicare Part D enrollees are expected to save $1.5 billion in out-of-pocket costs for prescription drugs, with Medicare itself saving $6 billion when compared to 2023 totals
Press Releases
Sen. Klobuchar, Watchdog, and Patient Advocates Discuss Lowering Drug Costs, New Report on Big Pharma Price-Gouging Patent Tactics
With the second anniversary of the Biden-Harris Inflation Reduction Act approaching and its cost-lowering Medicare drug price negotiations nearing the finish line, today Senator Amy Klobuchar (D-MN) joined Patients For Affordable Drugs for a briefing hosted by government watchdog Accountable.US to discuss lowering drug costs for everyday Americans
Press Releases
MEMO: Where Big Pharma’s Fight to Keep Price Gouging Seniors Stands in the Courts
This week, the Biden-Harris administration will announce final negotiated prices Medicare negotiated under the Inflation Reduction Act. This is the first time in history Medicare has been able to use its authority to lower prescription drug costs for seniors. And the big drug companies do not like it.
In The News
- Salon: Big Pharma “unleashed an army” of lawyers to avoid lowering Medicare drug costs: report
- Yahoo! Finance: Big Pharma: The government revealed its list of negotiated drug prices. Here are the reactions.
- Common Dreams: ‘New Era of Affordability’: Historic Medicare Negotiations Slash Drug Prices
- The Hill: Drugmakers in Medicare negotiations spent more on shareholder payments and marketing than R&D last year: Report
- Rolling Stone: How Big Pharma is Fueling a Radical MAGA Agenda
- The Guardian: US Pharma group opposing abortion pill restrictions also backs Republicans attacking drug
Additional Research
- Conservative Groups Push to Overturn Inflation Reduction Act After $1M in PhRMA Contributions
- Fifth Circuit Pharma Conflicts
- PhRMA Gave Nearly $30K in Illegal Dark Money to Fight Whitmer’s COVID Measures
- PhRMA Gave $16M to Block Drug Price Negotiations in 2022
- PhRMA Donates $300K to RAGA Despite Ongoing Legal Challenges
- PhRMA Gave $530K to Conservative Groups Tied to Leonard Leo and Project 2025 in 2022
- PhRMA’s Latest 2022 IRS Filing Shows Over $1.2 Million In Payments To Opponents of Medicare Drug Price Negotiations
- REPORT: Profits & Investor Handouts Soar Among Top 5 Pharma Companies Amid Industry Price Hikes
- Drug Company Insider Stock Dumping Surged as Taxpayer-Funded Vaccines Moved Toward Approval
Stay Informed
Get the latest news on how we’re holding big business, government officials, and special interests accountable, and what you can do to get involved.
By submitting your cell phone number you are agreeing to receive periodic text messages from this organization. Message and data rates may apply. Text HELP for more information. Text STOP to stop receiving messages.